A publicly traded pharmaceutical company negotiated clinical trial agreements in the U.S. in connection with a Phase III clinical trial for a novel small molecule therapeutic. Our firm represented the company in its negotiation.
Pharmaceutical Company Negotiates Clinical Trial Agreements
Lead Contacts
